469 related articles for article (PubMed ID: 28685652)
1. The Ubiquitous Pharmacogenomics consortium: making effective treatment optimization accessible to every European citizen.
Manson LE; van der Wouden CH; Swen JJ; Guchelaar HJ
Pharmacogenomics; 2017 Jul; 18(11):1041-1045. PubMed ID: 28685652
[No Abstract] [Full Text] [Related]
2. Ubiquitous Pharmacogenomics (U-PGx): The Time for Implementation is Now. An Horizon2020 Program to Drive Pharmacogenomics into Clinical Practice.
Cecchin E; Roncato R; Guchelaar HJ; Toffoli G;
Curr Pharm Biotechnol; 2017; 18(3):204-209. PubMed ID: 28044932
[TBL] [Abstract][Full Text] [Related]
3. Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium.
van der Wouden CH; Cambon-Thomsen A; Cecchin E; Cheung KC; Dávila-Fajardo CL; Deneer VH; Dolžan V; Ingelman-Sundberg M; Jönsson S; Karlsson MO; Kriek M; Mitropoulou C; Patrinos GP; Pirmohamed M; Samwald M; Schaeffeler E; Schwab M; Steinberger D; Stingl J; Sunder-Plassmann G; Toffoli G; Turner RM; van Rhenen MH; Swen JJ; Guchelaar HJ;
Clin Pharmacol Ther; 2017 Mar; 101(3):341-358. PubMed ID: 28027596
[TBL] [Abstract][Full Text] [Related]
4. Veterans Affairs Pharmacogenomic Testing for Veterans (PHASER) clinical program.
Dong OM; Bates J; Chanfreau-Coffinier C; Naglich M; Kelley MJ; Meyer LJ; Icardi M; Vassy JL; Sriram P; Heise CW; Rivas S; Ribeiro M; Jacobitz R; Rozelle S; Chapman JG; Voora D
Pharmacogenomics; 2021 Feb; 22(3):137-144. PubMed ID: 33403869
[TBL] [Abstract][Full Text] [Related]
5. Characterizing Pharmacogenomic-Guided Medication Use With a Clinical Data Repository.
Mathias PC; Hendrix N; Wang WJ; Keyloun K; Khelifi M; Tarczy-Hornoch P; Devine B
Clin Pharmacol Ther; 2017 Aug; 102(2):340-348. PubMed ID: 28073152
[TBL] [Abstract][Full Text] [Related]
6. Clinical Trial Designs to Support Clinical Utility of Pharmacogenomic Testing.
Drozda K; Pacanowski MA
Pharmacotherapy; 2017 Sep; 37(9):1000-1004. PubMed ID: 28605049
[TBL] [Abstract][Full Text] [Related]
7. Host genetic profiling to increase drug safety in colorectal cancer from discovery to implementation.
Cecchin E; De Mattia E; Ecca F; Toffoli G
Drug Resist Updat; 2018 Jul; 39():18-40. PubMed ID: 30075835
[TBL] [Abstract][Full Text] [Related]
8. Variant discovery using next-generation sequencing and its future role in pharmacogenetics.
Russell LE; Schwarz UI
Pharmacogenomics; 2020 May; 21(7):471-486. PubMed ID: 32338137
[TBL] [Abstract][Full Text] [Related]
9. Primary care physician experiences with integrated pharmacogenomic testing in a community health system.
Lemke AA; Hutten Selkirk CG; Glaser NS; Sereika AW; Wake DT; Hulick PJ; Dunnenberger HM
Per Med; 2017 Sep; 14(5):389-400. PubMed ID: 29754567
[TBL] [Abstract][Full Text] [Related]
10. Generating evidence for precision medicine: considerations made by the Ubiquitous Pharmacogenomics Consortium when designing and operationalizing the PREPARE study.
van der Wouden CH; Böhringer S; Cecchin E; Cheung KC; Dávila-Fajardo CL; Deneer VHM; Dolžan V; Ingelman-Sundberg M; Jönsson S; Karlsson MO; Kriek M; Mitropoulou C; Patrinos GP; Pirmohamed M; Rial-Sebbag E; Samwald M; Schwab M; Steinberger D; Stingl J; Sunder-Plassmann G; Toffoli G; Turner RM; van Rhenen MH; van Zwet E; Swen JJ; Guchelaar HJ;
Pharmacogenet Genomics; 2020 Aug; 30(6):131-144. PubMed ID: 32317559
[TBL] [Abstract][Full Text] [Related]
11. Non-interventional cardiologists' perspectives on the role of pharmacogenomic testing in cardiovascular medicine.
Deininger KM; Page RL; Lee YM; Kauffman YS; Johnson SG; Oreschak K; Aquilante CL
Per Med; 2019 Mar; 16(2):123-132. PubMed ID: 30543145
[TBL] [Abstract][Full Text] [Related]
12. Multisite investigation of strategies for the clinical implementation of pre-emptive pharmacogenetic testing.
Duarte JD; Dalton R; Elchynski AL; Smith DM; Cicali EJ; Lee JC; Duong BQ; Petry NJ; Aquilante CL; Beitelshees AL; Empey PE; Johnson JA; Obeng AO; Pasternak AL; Pratt VM; Ramsey LB; Tuteja S; Van Driest SL; Wiisanen K; Hicks JK; Cavallari LH;
Genet Med; 2021 Dec; 23(12):2335-2341. PubMed ID: 34282303
[TBL] [Abstract][Full Text] [Related]
13. The challenges of implementing pharmacogenomic testing in the clinic.
Moyer AM; Caraballo PJ
Expert Rev Pharmacoecon Outcomes Res; 2017 Dec; 17(6):567-577. PubMed ID: 28949250
[TBL] [Abstract][Full Text] [Related]
14. PACE Forward-Making Pharmacogenomics Testing Available for Real-Life Clinical Utility.
Lazaridis KN
Clin Pharmacol Ther; 2019 Jan; 105(1):42-44. PubMed ID: 30520030
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetics in the clinical analysis laboratory: clinical practice, research, and drug development pipeline.
Miscio G; Paroni G; Bisceglia P; Gravina C; Urbano M; Lozupone M; Piccininni C; Prisciandaro M; Ciavarella G; Daniele A; Bellomo A; Panza F; Di Mauro L; Greco A; Seripa D
Expert Opin Drug Metab Toxicol; 2019 Sep; 15(9):751-765. PubMed ID: 31512953
[No Abstract] [Full Text] [Related]
16. Electronic Medical Record-Integrated Pharmacogenomics and Related Clinical Decision Support Concepts.
Caraballo PJ; Bielinski SJ; St Sauver JL; Weinshilboum RM
Clin Pharmacol Ther; 2017 Aug; 102(2):254-264. PubMed ID: 28390138
[TBL] [Abstract][Full Text] [Related]
17. Potential of whole-genome sequencing-based pharmacogenetic profiling.
Caspar SM; Schneider T; Stoll P; Meienberg J; Matyas G
Pharmacogenomics; 2021 Feb; 22(3):177-190. PubMed ID: 33517770
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of clinical impact of pharmacogenomics knowledge involved in CPIC guidelines on Chinese pediatric patients.
Qin W; Du Z; Xiao J; Duan H; Shu Q; Li H
Pharmacogenomics; 2020 Feb; 21(3):209-219. PubMed ID: 31967514
[No Abstract] [Full Text] [Related]
19. [Personalized drug therapy based on genetics. Possibilities and examples from clinical practice].
Stingl JC; Just KS; Kaumanns K; Schurig-Urbaniak M; Scholl C; von Mallek D; Brockmöller J
Internist (Berl); 2016 Mar; 57(3):289-97. PubMed ID: 26830424
[TBL] [Abstract][Full Text] [Related]
20. Development of the PGx-Passport: A Panel of Actionable Germline Genetic Variants for Pre-Emptive Pharmacogenetic Testing.
van der Wouden CH; van Rhenen MH; Jama WOM; Ingelman-Sundberg M; Lauschke VM; Konta L; Schwab M; Swen JJ; Guchelaar HJ
Clin Pharmacol Ther; 2019 Oct; 106(4):866-873. PubMed ID: 31038729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
